Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 2/2010

01-04-2010 | Case Report

Pulmonary Toxoplasmosis, a Rare but Severe Manifestation of a Common Opportunistic Infection in Late HIV Presenters: Report of Two Cases

Authors: H. Kovari, C. Ebnöther, A. Schweiger, N. Berther, H. Kuster, H. F. Günthard

Published in: Infection | Issue 2/2010

Login to get access
Metadata
Title
Pulmonary Toxoplasmosis, a Rare but Severe Manifestation of a Common Opportunistic Infection in Late HIV Presenters: Report of Two Cases
Authors
H. Kovari
C. Ebnöther
A. Schweiger
N. Berther
H. Kuster
H. F. Günthard
Publication date
01-04-2010
Publisher
Urban & Vogel
Published in
Infection / Issue 2/2010
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-009-9367-5

Other articles of this Issue 2/2010

Infection 2/2010 Go to the issue

Clinical and Epidemiological Study

Contribution of Two Molecular Assays as Compared to Selective Culture for MRSA Screening in a Low MRSA Prevalence Population

Correspondence

Lactococcus lactis Catheter-Related Bacteremia in an Infant

Review

Nocardiosis: Updated Clinical Review and Experience at a Tertiary Center

Clinical and Epidemiological Study

A Seven-Year Prospective Study on Spondylodiscitis: Epidemiological and Microbiological Features

Correspondence

Infective Endocarditis Complicated by Intracerebral Hemorrhage due to Lactococcus lactis subsp. cremoris

Images in Infection

Two Cases of Presumably Travel-Related Subcutaneous Cysticercosis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits